Altis (n = 60) | Solyx (n = 44) | Abbrevo (n = 93) | Intergroup comparison p-value | Data available Altis/Solyx/Abbrevo(n) | |
Uroflowa | |||||
MFR Preoperative, mean ± SD | 34.9 ± 15.2 | 29.2 ± 11.0 | 30.0 ± 13.1 | 0.206 | 37/23/25 |
PVR Preoperative, mean ± SD | 25.6 ± 25.2 | 26.5 ± 29.0 | 27.3 ± 28.8 | 0.912 | 37/23/24 |
MFR Postoperative, mean ± SD | 26.6 ± 14.2 | 28.2 ± 12.2 | 30.2 ± 10.1 | 0.541 | 37/23/25 |
PVR Postoperative, mean ± SD | 43.6 ± 37.4 | 39.4 ± 33.8 | 14.0 ± 16.2 | 0.002 | 37/23/24 |
MFR change, mean ± SD | −8.3 ± 16.7 | −1.0 ± 12.3 | 0.27 ± 15.5 | 0.064 | 37/23/25 |
PVR change, mean ± SD | 18.0 ± 41.9 | 12.8 ± 41.5 | −13.3 ± 35.8 | 0.012 | 37/23/24 |
MFR change (intragroup preop vs postop) | 0.005 | 0.701 | 0.931 | 37/23/25 | |
PVR change (intragroup preop vs postop) | 0.013 | 0.153 | 0.082 | 37/23/24 | |
Symphisis-Sling distance | |||||
Sling distance at valsalva, mean ± SD | 13.8 ± 2.9 | 14.5 ± 2.9 | 13.8 ± 3.6 | 0.579 | 49/32/29 |
Sling distance at rest, mean ± SD | 15.7 ± 4.5 | 16.3 ± 3.7 | 15.9 ± 4.5 | 0.843 | 49/32/29 |
(n): number of cases; MFR: maximum flow rate; PVR: post void residual; assessment performed at uroflowmetry prior to consent for continence surgery Sling distance (mm).
Pairwise comparison, p-values (Bonferroni method); PVR postoperative, p = 1.00 (Altis vs Solyx); p = 0.002 (Altis vs Abbrevo); p = 0.023 (Solyx vs Abbrevo), PVR change, p = 1.00 (Altis vs Solyx); p = 0.012 (Altis vs Abbrevo), p = 0.086 (Solyx vs Abbrevo).
↵a Uroflow:included all cases with both pre or postop uroflow data available for comparison, excluded patients with voided volume <150 ml.